SSIM
DERM icon

Sheets Smith Investment Management’s Journey Medical DERM Stock Holding History

Sheets Smith Investment Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$946K Buy
+132,904
New +$964K 0.61% 63

Other funds holding DERM

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Sheets Smith Investment Management's DERM Position: Q3 2025 in Review

Sheets Smith Investment Management opened a new position in Journey Medical (DERM) in Q3 2025: 132,904 shares worth $946K. The stake represents 0.61% of the portfolio and ranks #63 among its holdings.

68 funds tracked by Wall St. Rank hold DERM as of Q3 2025.

  • Sheets Smith Investment Management held 132,904 shares of Journey Medical worth $946K as of Q3 2025.
  • Journey Medical was a new Sheets Smith Investment Management position in Q3 2025.
  • Journey Medical made up 0.61% of Sheets Smith Investment Management's portfolio in Q3 2025, its #63 holding.
  • 68 funds tracked by Wall St. Rank held Journey Medical as of Q3 2025.

Based on Sheets Smith Investment Management's 13F filing for Q3 2025, filed 8 Oct 2025.